Sekihara was stopped by Takumi Hamada with a slam and punches at 4:56 of the third round on November 8 at LaLa Arena Tokyo-Bay in Chiba. He lost consciousness and was taken to the Chiba Prefectural General Emergency Medical Center, where he underwent emergency surgery for an acute subdural hematoma, bleeding between the brain and its protective membrane. According to RIZIN, he survived the first operation, but his condition deteriorated suddenly the next morning and he needed a second.
It was not the first time. In May 2022, Sekihara suffered a subdural hematoma in a bout for the DEEP promotion, Japanese outlet Gong Kakutogi reported, and he returned to competition in May 2024. In the years since, he reworked his style from a striking-heavy approach to one built around grappling and competed several times a year. It is that history, a fighter returning to active competition after one serious brain bleed only to suffer another, that has prompted pointed questions across the sport. MMA Mania, which described the 2022 injury as one that almost ended his life and career, wrote that there are real questions about whether Sekihara should have been allowed to continue fighting after it, and argued that Japan has a poor track record in combat sports when it comes to these injuries.
Some of those questions are about process. At the post-event press conference on the night, RIZIN CEO Nobuyuki Sakakibara said Sekihara was being treated in hospital and that the injury was not life-threatening, according to Japanese outlets ENCOUNT and Gong Kakutogi. Within days, the promotion was describing a fighter who had survived two emergency operations and whose prognosis was uncertain. RIZIN has asked the public not to spread unverified information about his condition.
The larger questions are about structure. Unlike in the United States, where state athletic commissions license fighters, review medical histories and impose medical suspensions, Japanese MMA operates without a government athletic commission. Promotions effectively regulate themselves, and, as a 2020 analysis drawing on veteran fighter manager Shu Hirata pointed out, they hire their own doctors. That means decisions about whether a fighter with a serious injury history is cleared to compete again rest with the promotions and the physicians they engage, rather than an independent regulator. It also means there is no single authority responsible for tracking a fighter’s medical history as he moves between promotions, as Sekihara did between DEEP and RIZIN. What medical evaluation Sekihara underwent before his return in 2024, and before RIZIN 55, has not been made public.
Japanese boxing, by contrast, does have a regulator, and its recent history shows both the risks of the sport and how quickly reform can follow tragedy. On August 2, 2025, two boxers, Shigetoshi Kotari and Hiromasa Urakawa, both 28, suffered fatal subdural hematomas in separate bouts on the same card at Tokyo’s Korakuen Hall. The Japan Boxing Commission responded by cutting Oriental and Pacific Boxing Federation title fights from 12 rounds to 10, opening an investigation and holding emergency meetings on safety. Those deaths came less than two years after 23-year-old Kazuki Anaguchi died following brain surgery after a December 2023 bout.
None of this is unique to Japan, and it would be wrong to suggest the problem is solved elsewhere. Even in the United States, commissions operate largely independently of each other, standards vary from state to state, and medical records are shared on a case-by-case basis; regulators there have long acknowledged that a national medical registry would be better but has proved difficult to build. Severe injuries happen under every system. The difference in Japan is that, in MMA, there is no independent body at all whose job is to ask the question at the heart of Sekihara’s case: whether a fighter who has already suffered one brain bleed should be cleared to fight again.
For now, the sport’s attention is where it should be, on a young man in a hospital bed and a family waiting for news. But when the immediate crisis passes, Japanese MMA will face a harder conversation about who makes that decision, how fighters’ injury histories are tracked across promotions, and whether self-regulation is enough when the injuries in question are to the brain.